News

Ultibro Breezhaler Improved Cardiac Function in COPD Patients with Lung Hyperinflation

Novartis’ Ultibro Breezhaler provided noteworthy improvements in cardiac and lung function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation (overinflated lungs) when compared to placebo, a new research study found. The study reporting the findings, “Effect of lung deflation with indacaterol plus glycopyrronium on ventricular…